The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

Published on 8 May 2021 on Benzinga via Yahoo Finance

Benzinga spoke with Irwin Simon, CEO of the new combined company. Jazz Pharmaceuticals (NASDAQ:...

Read the rest of the article

Start tracking your investments with Statfolio

Benzinga spoke with Irwin Simon, CEO of the new combined company. Jazz Pharmaceuticals (NASDAQ:...

Benzinga via Yahoo Finance 8 May 2021

Holding Inc. CDAY is a human capital management software company. The Zacks Consensus Estimate fo...

Zacks via Yahoo Finance 6 May 2021

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition ...

Benzinga 6 May 2021

Jazz Pharmaceuticals JAZZ delivered adjusted earnings of $3.92 per share for the first quarter of...

Zacks via Yahoo Finance 5 May 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Pea...

Benzinga 4 May 2021

In a report released yesterday, Danielle Brill from Raymond James maintained a Hold rating on GW...

SmarterAnalyst 4 May 2021

Shares of Aphria Inc. shed 3.56% to $15.45 Thursday, on what proved to be an all-around positive...

Market Watch 29 Apr 2021

Shares of Aphria Inc. shed 0.74% to $14.67 Tuesday, on what proved to be an all-around mixed trad...

Market Watch 27 Apr 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Pea...

Benzinga 27 Apr 2021

NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored the medical marijuana market in ...

WFMZ Eastern Pennsylvania and Western New Jersey 26 Apr 2021